Skip to main content

Cardiac Arrest clinical trials at UCSF

3 in progress, 2 open to eligible people

Showing trials for
  • Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

    open to eligible people ages 18 years and up

    A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

    San Francisco, California and other locations

  • The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

    open to all eligible people

    Sudden cardiac death (SCD) remains a major cause of mortality within developed nations despite aggressive efforts to reduce its societal burden. Despite extensive clinical and genetic investigations, a subgroup of cardiac arrests remain unexplained, highlighting the potential contribution of additional cardiac conditions that may not be identified with contemporary diagnostic algorithms. The EPS ARREST study aims to evaluate the role of invasive electrophysiology study within this patient population.

    San Francisco, California and other locations

  • Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

    Sorry, not yet accepting patients

    This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.

    San Francisco, California and other locations

Our lead scientists for Cardiac Arrest research studies include .

Last updated: